UroFors meets… DFBK

Meet BIOTYPE at the 15th Symposium des Deutschen Forschungsverbundes Blasenkarzinom e.V.!

BIOTYPE is attending the 15th Symposium des Deutschen Forschungsverbundes Blasenkarzinom e.V. from 24 to 25 January 2025 in Jena!

Here are the key highlights:

Expert Insights: Our CEO, Timm Zörgiebel, will present "Personalized Medicine for Bladder Cancer: Stratification through Targeted Panels in Molecular Precision Diagnostics"—shedding light on innovative approaches to precision diagnostics in uro-oncology.

Assay Portfolio: BIOTYPE offers solutions for various cancers, including bladder cancer, with a focus on key biomarkers like FGFR3. Our uro-oncology portfolio will expand in 2025, and we’ll share exclusive insights into our plans at the symposium.

MODAPLEX Platform: Streamlined testing for multiple biomarkers in less than 5 hours, conserving FFPE tissue and enabling fast, efficient workflows.

Applications: Supporting molecular precision diagnostics for bladder cancer samples, driving improved patient outcomes.

Our delegates Dr. Timm Zörgiebel, Sabine Kießling-Parr, Vanessa Grunwald, and Dr. Rebekka Weißbach will be on-site to share insights and discuss ideas in the field of uro-oncology.

We look forward to seeing you in Jena!